Remi Gaston-Dreyfus
Director/Board Member at BIONIK LABORATORIES CORP.
Net worth: 689 550 $ as of 29/09/2023
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
André-Jacques Auberton-Hervé | M | 62 |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020.
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | 6 years |
Richard Russo | M | 44 | 4 years | |
Michal Prywata | M | 33 | 14 years | |
Joseph Martin | M | 76 |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | 6 years |
Yves Lévy | M | - |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | 4 years |
Audrey Thévenon | M | 46 |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | 6 years |
Charles Matine | M | 65 |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | 6 years |
Michael Prywata | M | - |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | - |
Laurent Hanot | M | - |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | 4 years |
Jiong Ma | M | 60 |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | 3 years |
Mireille Centlivre | M | - |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | 4 years |
Dan Gonsalves | M | - | 3 years | |
Pascale Augé | M | 53 |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | - |
Mark Eiseman | M | - | 2 years | |
John Smathers | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eric Michel Dusseux | M | 56 |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The company is based in Watertown, MA. The company was founded by Michael Prywata. | 4 years |
Peter Bloch | M | 64 | 6 years | |
Peter Malone | M | 74 | 4 years | |
Leslie Markow | F | 63 | 7 years | |
Robert Hariri Gordon | M | 65 | 2 years | |
Marc Mathieu | M | 64 | 3 years | |
Timothy A. McCarthy | M | - | 2 years | |
Loren Wass | M | 62 | 3 years | |
Renaud Maloberti | M | 55 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 19 | 79.17% |
France | 6 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Remi Gaston-Dreyfus
- Personal Network